Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent
Clinical and Investigative Medicine · 03.10.2021 · 44 (3) · E64-E71
DOI: 10.25011/cim.v44i3.36657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Investigative Medicine, erschienen am 03.10.2021. Verfasst von Ana Vera-Cruz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada and Chronic Disease Program, Ottawa Hospital Research…. Hauptthemen laut MEDLINE: Anti-HIV Agents, Antimicrobial Cationic Peptides. Die Arbeit wurde bisher 16-mal zitiert (Crossref).
Abstract (Originalsprache)
Human immunodeficiency virus (HIV) continues to have a profound global health impact. New infections continue at a high rate despite the development of prophylactic therapies, prompting the need for development of novel preventative approaches. Antimicrobial peptides (AMPs), such as LL-37, display broad microbicidal properties and have potential as anti-HIV agents. LL-37 has been studied for its anti-HIV activity and the limited data available suggest it can inhibit HIV infection in primary T cells as well as exert inhibitory effects on key HIV enzymes. Its immunomodulatory properties may both enhance and inhibit HIV replication. In addition, LL-37 has both 1) the ability to kill other sexually-transmitted pathogens and 2) spermicidal activity; thus, it is a good candidate for multipurpose prevention technology. Further investigation of its anti-HIV activity is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada and Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada .
- Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada and Department of Obstetrics/Gynecology, University of Ottawa, Ottawa, ON, Canada.
- Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada , Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada and Division of Infectious Disease, The O…
Zitieren
APA
Vera-Cruz, A., Tanphaichitr, N., & Angel, J. B. (2021). Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent. Clinical and Investigative Medicine, 44(3), E64-E71. https://doi.org/10.25011/cim.v44i3.36657
Vancouver
Vera-Cruz A, Tanphaichitr N, Angel JB. Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent. Clinical and Investigative Medicine. 2021;44(3):E64-E71. doi:10.25011/cim.v44i3.36657
BibTeX
@article{VeraCruz2021,
author = {Vera-Cruz, Ana and Tanphaichitr, Nongnuj and Angel, Jonathan B},
title = {Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent},
journal = {Clinical and Investigative Medicine},
year = {2021},
volume = {44},
number = {3},
pages = {E64--E71},
doi = {10.25011/cim.v44i3.36657}
}
EUVIMED